Literature DB >> 18631171

Balance between vasoconstriction and enhanced oxygen delivery.

Pedro Cabrales1, Amy G Tsai, Marcos Intaglietta.   

Abstract

BACKGROUND: Hemoglobin (Hb) solutions are potential alternatives to blood transfusion when native oxygen (O(2))-carrying capacity is lacking. Polymerized bovine Hb (PBH) solutions are characterized by its vasoactivity, low O(2) affinity, oncotic effect, prolonged shelf life, and stability. Responses to facilitated O(2) transport, after exchange transfusion with PBH, were studied in the hamster window chamber model during acute extreme anemia to determine how PBH affects microvascular perfusion and tissue oxygenation. STUDY DESIGN AND METHODS: An anemic state was induced by hemodilution with a plasma expander (70-kDa dextran). After hemodilution, animals were randomly assigned to exchange transfusion groups based on the concentration of PBH used, namely, PBH at 13 g(Hb) per dL (PBH13), PBH diluted to 8 or 4 g(Hb) per dL in albumin solution at matching colloidal osmotic pressure (COP; PBH8 and PBH4), and no PBH only albumin solution at matching COP (PBH0). Measurement of systemic variables, microvascular hemodynamics, capillary perfusion, and intravascular and tissue O(2) levels was performed at 11 percent Hct.
RESULTS: Restitution of O(2)-carrying capacity with PBH13 restored higher arterial pressure and triggered vasoconstriction, low perfusion, and higher peripheral resistance. Groups PBH4 and PBH0 had lower arterial pressures than Group PBH13. Groups PBH4 and PBH8 maintained higher perfusion and functional capillary density than Groups PBH13 and PBH0. In all groups, blood gas variables and acid-base balance were recovered proportional to microvascular perfusion. Arterial O(2) tensions were improved for Groups PBH4 and PBH8 by preventing O(2) precapillary release and increasing O(2) reserve.
CONCLUSION: Further studies to establish acellular Hb optimal dosage, efficacy, safety, and effects on outcome are indicated before these solutions are implemented in routine practice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18631171      PMCID: PMC2747808          DOI: 10.1111/j.1537-2995.2008.01834.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  27 in total

Review 1.  Blood substitutes.

Authors:  Robert M Winslow
Journal:  Curr Opin Hematol       Date:  2002-03       Impact factor: 3.284

2.  pO(2) measurements by phosphorescence quenching: characteristics and applications of an automated system.

Authors:  Heinz Kerger; Gesine Groth; Armin Kalenka; Peter Vajkoczy; Amy G Tsai; Marcos Intaglietta
Journal:  Microvasc Res       Date:  2003-01       Impact factor: 3.514

3.  Resuscitation from hemorrhagic shock with MalPEG-albumin: comparison with MalPEG-hemoglobin.

Authors:  Reto Wettstein; Pedro Cabrales; Dominique Erni; Amy G Tsai; Robert M Winslow; Marcos Intaglietta
Journal:  Shock       Date:  2004-10       Impact factor: 3.454

4.  Microvascular measurements by video image shearing and splitting.

Authors:  M Intaglietta; W R Tompkins
Journal:  Microvasc Res       Date:  1973-05       Impact factor: 3.514

5.  Application of the "two-slit" photometric technique to the measurement of microvascular volumetric flow rates.

Authors:  H H Lipowsky; B W Zweifach
Journal:  Microvasc Res       Date:  1978-01       Impact factor: 3.514

6.  The molecular mechanism of hemoglobin-facilitated oxygen diffusion.

Authors:  J B Wittenberg
Journal:  J Biol Chem       Date:  1966-01-10       Impact factor: 5.157

Review 7.  Oxygen gradients in the microcirculation.

Authors:  Amy G Tsai; Paul C Johnson; Marcos Intaglietta
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

8.  Microvascular pressure and functional capillary density in extreme hemodilution with low- and high-viscosity dextran and a low-viscosity Hb-based O2 carrier.

Authors:  Pedro Cabrales; Amy G Tsai; Marcos Intaglietta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-02-19       Impact factor: 4.733

9.  Oxygen delivery and consumption in the microcirculation after extreme hemodilution with perfluorocarbons.

Authors:  Pedro Cabrales; Amy G Tsai; John A Frangos; Juan C Briceño; Marcos Intaglietta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-07       Impact factor: 4.733

10.  Resuscitation with polyethylene glycol-modified human hemoglobin improves microcirculatory blood flow and tissue oxygenation after hemorrhagic shock in awake hamsters.

Authors:  Reto Wettstein; Amy G Tsai; Dominique Erni; Robert M Winslow; Marcos Intaglietta
Journal:  Crit Care Med       Date:  2003-06       Impact factor: 7.598

View more
  5 in total

Review 1.  Perfusion vs. oxygen delivery in transfusion with "fresh" and "old" red blood cells: the experimental evidence.

Authors:  Amy G Tsai; Axel Hofmann; Pedro Cabrales; Marcos Intaglietta
Journal:  Transfus Apher Sci       Date:  2010-06-19       Impact factor: 1.764

Review 2.  Blood substitutes: evolution from noncarrying to oxygen- and gas-carrying fluids.

Authors:  Pedro Cabrales; Marcos Intaglietta
Journal:  ASAIO J       Date:  2013 Jul-Aug       Impact factor: 2.872

3.  Comprehensive characterization of tense and relaxed quaternary state glutaraldehyde polymerized bovine hemoglobin as a function of cross-link density.

Authors:  Xiangming Gu; Crystal Bolden-Rush; Clayton T Cuddington; Donald A Belcher; Chintan Savla; Ivan S Pires; Andre F Palmer
Journal:  Biotechnol Bioeng       Date:  2020-06-12       Impact factor: 4.530

4.  Vasoactive hemoglobin solution improves survival in hemodilution followed by hemorrhagic shock.

Authors:  Beatriz Y Salazar Vázquez; C Makena Hightower; Judith Martini; Catalina Messmer; Barbara Frienesenecker; Pedro Corbels; Amy G Tsai; Marcos Intaglietta
Journal:  Crit Care Med       Date:  2011-06       Impact factor: 7.598

5.  Dose-Dependent Hemodynamic, Biochemical, and Tissue Oxygen Effects of OC99 following Severe Oxygen Debt Produced by Hemorrhagic Shock in Dogs.

Authors:  William W Muir; Carlos L Del Rio; Yukie Ueyama; Bradley L Youngblood; Robert S George; Carl W Rausch; Billy S H Lau; Robert L Hamlin
Journal:  Crit Care Res Pract       Date:  2014-10-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.